QSYQ attenuates oxidative stress and apoptosis induced heart remodeling rats through different subtypes of NADPH-oxidase

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Yong ^a   Li, Chun ^a   Ouyang, Yuli ^a   Shi, Tianjiao ^a   Yang, Xiaomin ^a   Yu, Junda ^a   Qiu, Qi ^b   Han, Jing ^a   Wu, Yan ^a   Tang, Binghua ^a   Wang, Wei ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; CASPASE 3; GELATINASE A; MALONALDEHYDE; PROTEIN P53; QSYQ; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDITIS; CONTROLLED STUDY; HEART; HEART EJECTION FRACTION; HEART FAILURE; HEART INJURY; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 84879396623     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/824960     Document Type: Article

References (31)

1. Lloyd-Jones D., Adams R. J., Brown T. M., Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010 121 e46 e215 10.1161/CIRCULATIONAHA.109.192667
2. Ambardekar A. V., Buttrick P. M., Reverse remodeling with left ventricular assist devices a review of clinical, cellular, and molecular effects. Circulation: Heart Failure 2011 4 2 224 233 2-s2.0-79955929563 10.1161/CIRCHEARTFAILURE.110.959684
3. Wang Y., Chuo W. J., Li C., Guo S. Z., Chen J. X., Yu J. D., Wang W., Energy metabolism disorder and myocardial injury in chronic myocardial ischemia with Qi deficiency and blood stasis syndrome based on 2-DE proteomics. Chinese Journal of Integrative Medicine 2012 10.1007/s11655-012-1230-8
4. Blum A., Heart failure-new insights. The Israel Medical Association Journal 2009 11 2 105 111
5. Rashikh A., Ahmad S. J., Pillai K. K., Kohli K., Najmi A. K., Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy. Biomedicine and Pharmacotherapy 2012 66 2 138 143 2-s2.0-84858283021 10.1016/j.biopha.2011.11.020
6. Tsutsui H., Kinugawa S., Matsushima S., Oxidative stress and heart failure. American Journal of Physiology 2011 301 6 2181 2190 2-s2.0-82855169318 10.1152/ajpheart.00554.2011
7. Zhang M., Perino A., Ghigo A., Hirsch E., Shah A. M., NADPH oxidases in heart failure: poachers or gamekeepers? Antioxidants & Redox Signaling 2013 18 9 1024 1041 10.1089/ars.2012.4550
8. Schröder K., Zhang M., Benkhoff S., Mieth A., Pliquett R., Kosowski J., Kruse C., Lüdike P., Michaelis U. R., Weissmann N., Dimmeler S., Shah A. M., Brandes R. P., Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circulation Research 2012 110 9 1217 1225 2-s2.0-84858837415 10.1161/CIRCRESAHA.112.267054
9. Maksimenko A. V., Vavaev A. V., Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Heart International 2012 7 1 14 19 2-s2.0-84856660603 10.4081/hi.2012.e3
10. Hojo Y., Saito T., Kondo H., Role of apoptosis in left ventricular remodeling after acute myocardial infarction. Journal of Cardiology 2012 60 2 91 92
11. Hayakawa K., Takemura G., Kanoh M., Li Y., Koda M., Kawase Y., Maruyama R., Okada H., Minatoguchi S., Fujiwara T., Fujiwara H., Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 2003 108 1 104 109 2-s2.0-0038502520 10.1161/01.CIR.0000074225. 62168.68
12. Feng X., Liu X., Zhang W., Xiao W., p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. The EMBO Journal 2011 30 16 3397 3415 2-s2.0-80155174979 10.1038/emboj.2011.248
13. Abbate A., Bussani R., Amin M. S., Vetrovec G. W., Baldi A., Acute myocardial infarction and heart failure: role of apoptosis. International Journal of Biochemistry and Cell Biology 2006 38 11 1834 1840 2-s2.0-33748645920 10.1016/j.biocel.2006.04.010
14. Dai G., Zhang B., Guo Z., Application of central randomized system in project of clinical trial for secondary prevention of myocardial infarction by Qishen Yiqi Drop Pill. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007 27 7 653 656 2-s2.0-58149099616
15. Wang Y., Liu Z., Li C., Li D., Ouyang Y., Yu J., Guo S., He F., Wang W., Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of Qishenkeli acting on the coronary heart disease. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 2-s2.0-84859770257 10.1155/2012/698531 698531
16. Wang Y., Li C., Ouyang Y., Yu J., Guo S., Liu Z., Li D., Han J., Wang W., Cardioprotective effects of Qishenyiqi mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin-converting enzyme 2. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 10.1155/2012/978127 978127
17. Song X. J., Yang C. Y., Liu B., Wei Q., Korkor M. T., Liu J. Y., Yang P., Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response. International Journal of Medical Sciences 2011 8 7 564 572 2-s2.0-80054732357
18. Shirakabe A., Asai K., Hata N., Yokoyama S., Shinada T., Kobayashi N., Tomita K., Tsurumi M., Matsushita M., Mizuno K., Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failure. Journal of Cardiology 2012 59 3 374 382 2-s2.0-84860445639 10.1016/j.jjcc.2012.01.009
19. Burgoyne J. R., Mongue-Din H., Eaton P., Shah A. M., Redox signaling in cardiac physiology and pathology. Circulation Research 2012 111 8 1091 1106 10.1161/CIRCRESAHA.111.255216
20. Jiang Y., Miao Y., Yang L., Xue M., Guo C., Ma X., Yin H., Shi D., Chen K., Effect of chinese herbal drug-containing serum for activating-blood and dispelling-toxin on ox-LDL-induced inflammatory factors' expression in endothelial cells. Chinese Journal of Integrative Medicine 2012 18 1 30 33 2-s2.0-84856295270 10.1007/s11655-011-0849-1
21. Kuroda J., Sadoshima J., NADPH oxidase and cardiac failure. Journal of Cardiovascular Translational Research 2010 3 4 314 320 2-s2.0-77955516163 10.1007/s12265-010-9184-8
22. Bao M., Dai W., Li Y., Hu C., Rutaecarpine prevents hypoxia- reoxygenation-induced myocardial cell apoptosis via inhibition of NADPH oxidases. Canadian Journal of Physiology and Pharmacology 2011 89 3 177 186 2-s2.0-79952976830 10.1139/Y11-006
23. Nabeebaccus A., Zhang M., Shah A. M., NADPH oxidases and cardiac remodelling. Heart Failure Reviews 2011 16 1 5 12 2-s2.0-78650995039 10.1007/s10741-010-9186-2
24. Cangemi R., Celestini A., Del Ben M., Pignatelli P., Carnevale R., Proietti M., Calabrese C. M., Basili S., Violi F., Role of platelets in NOX2 activation mediated by TNF α in heart failure. Internal and Emergency Medicine 2012 28 10.1007/s11739-012-0837-2
25. Moe K. T., Yin N. O., Naylynn T. M., Khairunnisa K., Wutyi M. A., Gu Y., Atan M. S. M., Wong M. C., Koh T. H., Wong P., Nox2 and Nox4 mediate tumour necrosis factor- α -induced ventricular remodelling in mice. Journal of Cellular and Molecular Medicine 2011 15 12 2601 2613 2-s2.0-82455220308 10.1111/j.1582-4934.2011.01261.x
26. Dworakowski R., Alom-Ruiz S. P., Shah A. M., NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacological Reports 2008 60 1 21 28 2-s2.0-42549085269
27. van der Vliet A., NADPH oxidases in lung biology and pathology: host defense enzymes, and more. Free Radical Biology and Medicine 2008 44 6 938 955 2-s2.0-39949083961 10.1016/j.freeradbiomed.2007.11.016
28. Brandes R. P., Weissmann N., Schröder K., NADPH oxidases in cardiovascular disease. Free Radical Biology and Medicine 2010 49 5 687 706 2-s2.0-77955096004 10.1016/j.freeradbiomed.2010.04.030
29. Maejima Y., Kuroda J., Matsushima S., Ago T., Sadoshima J., Regulation of myocardial growth and death by NADPH oxidase. Journal of Molecular and Cellular Cardiology 2011 50 3 408 416 2-s2.0-79551588796 10.1016/j.yjmcc.2010.12.018
30. Chen T., Zhou X. Z., Zhang R. S., Zhang L. W., Discovery of regularities in the use of herbs in chinese medicine prescriptions. Chinese Journal of Integrative Medicine 2012 18 2 88 92 10.1007/s11655-011-0860-6
31. Ferreira A. S., Lopes A. J., Chinese medicine pattern differentiation and its implications for clinical practice. Chinese Journal of Integrative Medicine 2011 17 11 818 823 2-s2.0-84858383319